Bowel Cancer Screening Programme Cheshire and Merseyside NHS North West.

Slides:



Advertisements
Similar presentations
Bowel Cancer screening programme The Facts Third most common Cancer in the UK. The Second most common cause of cancer deaths in the UK (approx 16,100.
Advertisements

National Cancer Screening Programmes Bowel Screening Breast Screening Cervical Screening.
Bowel cancer screening in Learning Disability patients in Salford Nadia Awan (CT2) Rupa Gupta (ST5) Nasim Chaudhry (Consultant Psychiatrist)
1 Colorectal Cancer and Screening Cancer Screening Programs September 2013.
Spotlight on Colorectal Cancer Screening 1 1. Home Screening for Colon Cancer
Bowel Cancer & Bowel Cancer Screening Education and Awareness Sessions
Detecting Cancer Earlier Network Service 2014/15 Includes £40k for opportunistic targeted endorsement of bowel screening.
Direct Access Flexible Sigmoidoscopy Pathway for GPs
Bowel Cancer and Screening Dr M T Hendrickse Clinical Director/ Lead Colonoscopist Lancashire Bowel Screening Centre Blackpool Fylde and Wyre NHS Hospitals.
Colorectal Cancer & Screening Sept Sometimes there are things that may be hard to talk about… But not talking about them is even harder.
The primary care excellence model Increasing Colorectal Cancer Screening Uptake with a Patient Navigator Dr. Brian Mitchell, Co-Investigator Northern Ontario.

Mobilizing Newcomers and Immigrants to Cancer Screening Programs Funded by Public Health Agency of Canada (PHAC) The views expressed herein do not necessarily.
Bowel Cancer & Bowel Cancer Screening Education and Awareness Sessions.
Bowel Cancer and Screening
Bowel Cancer Awareness Claire Stephenson Health Promotion & Outreach Coordinator.
Integrated Cancer Screening Colorectal Cancer Screening.
Wilson and Jungner Criteria for Screening 1968
Maureen Sayer Health Improvement Practitioner Cheshire and Merseyside Bowel Cancer Screening Programme.
The Bowel Cancer Screening Programme Professor Tony Morris Director, National Endoscopy Training Centre, Liverpool President, British Society of Gastroenterology.
Bowel Cancer & Bowel Cancer Screening Education and Awareness Sessions Maureen Sayer Health Improvement Practitioner Cheshire and Merseyside BCSP.
Bowel Screening in Scotland – Current Challenges and Possible Solutions Prof. Bob Steele Ninewells Hospital, University of Dundee.
Bowel Cancer Alex Hill. Why screen for bowel cancer?  Bowel cancer causes deaths per yr  It may be detected at asymptomatic stage by simple, safe.
Reaching Sensory Impaired (Blind & Deaf) Communities – Research Project Marie Coughlin Cheshire & Merseyside 4 th January 2008.
Increasing awareness and early diagnosis of cancer An update from Primary Care Jo Preston Service Improvement Facilitator NECN Dr Bill Hall Primary Care.
Slides last updated: June 2015 CRC: CLINICAL FEATURES.
Colorectal Screening NZ Bowel Screening Pilot. WHO Screening criteria  Impt Health condition  Identifiable Latent or early stage  Understand natural.
SETTING UP THE SERVICE BY LYNN TOBIN. HOW DID WE GET HERE? ABUNDENCE OF EVIDENCE PROVIDING JUSTIFICATION FOR BOWEL CANCER SCREENING.
Better Health. No Hassles. Colorectal Cancer Facts – The 2 nd leading cause cancer-related deaths in the Nation – Highly preventable – Caused 49,920 deaths.
1 Cervical Screening Programme, England, : Graphs.
Initiatives for Reducing Health Inequalities in the Bowel Cancer Screening Programme.
PREPARED BY National Bowel Screening Programme Meeting 19 August 2015.
Chester Ellesmere Port & Neston Rural Making sure you get the healthcare you need West Cheshire CCG Strategy Dr Andy McAlavey Medical Director West Cheshire.
Reaching Sensory Impaired (Blind & Deaf) Communities – Research Findings Lynn Tobin Cheshire & Merseyside August 2008.
Cheshire & Merseyside Bowel Cancer Screening Programme April 2008.
Bowel Cancer Screening in West Herts- The First 2 Years! Alistair King Consultant Gastroenterologist.
Improving Cancer Outcomes in Camden Dr Lucia Grun 19 March 2014.
Definition Signs & symptoms Treatment Root of the disease.
Cheshire & Merseyside Bowel Cancer Screening Programme April 2008.
Interventions for Clients with Colorectal Cancer.
Colorectal Cancer Screening Implementation of a public health programme An Expert Group on Colorectal Cancer Screening Cancer Society of Finland, Finnish.
First results of a pilot population-based faecal occult blood colorectal cancer screening program B. DENIS, P. PERRIN, J.F. EBELIN, P. WEBER, E. KALTENBACH,
Bowel Cancer Awareness Month. Age – Majority of cases occur over age 50 Diet – Diet high in red or processed meat and low in fibre increases risk Lifestyle.
Insert name of presentation on Master Slide Bowel Screening in Welsh Prisons Hayley Heard Head of Programme.
Working with People with Learning Disabilities Directed Enhanced Service (DES) – Learning Disabilities 2008/09 Appendix 5.
March 2010 Having a Bowel Test Professional Pack.
NHS Health Check programme An opportunity to engage 15 million people to live well for longer Louise Cleaver National Programme Support Manager.
NHS Cambridgeshire (formerly Cambridgeshire PCT) Visit our web site: EVALUATION OF NHS HEALTH CHECKS.
Early Diagnosis of Gynaecological Cancer Rob Gornall Consultant Gynaecology GHNHST.
A Pharmacy Based Bowel Cancer Screening Program. Did You Know? Bowel cancer kills more Australians each year than breast or prostate cancer (AIHW 2012.
FIT Programme (Faecal Immunohistochemical Test)
Screening for Life 2017.
CRC 101; Part One Julie Banahan, RN, BSN, OCN
CRC 101; Part One Julie Banahan, RN, BSN, OCN
Colorectal Cancer: Risk Prevention and Diagnosis
Bowel cancer screening update GP education event 28 Nov 2017
Dr James Carlton, Medical Adviser
Prevention and Early Diagnosis of Cancer Ongar Health Centre Patient Forum 7th March 2018 Sue White Cancer Research UK Facilitator.
The Bowel Screening Programme in Wales
Colorectal Cancer Mr Eoghan Condon, MD,FRCSI.
BOWEL CANCER SCREENING 11/7/18
Bowel Screening in Wales
What to look out for and why?
Barts Health Trust 2WW Colorectal Workshop Dr Angela Wong,
Colorectal Cancer Cancer Alliance Work
BOWEL CANCER SCREENING IN LEWISHAM
FIT for symptomatic patients
Louise Newton & Cathy Corcoran
Colorectal 2 week wait pathways and “Getting FIT”
Faecal Immunochemistry Test - qFIT
Presentation transcript:

Bowel Cancer Screening Programme Cheshire and Merseyside NHS North West

Aims and Objectives To provide information about the BCSP To give a Public Health perspective To raise awareness of health inequalities To increase knowledge of Bowel Cancer symptoms

Public Health Perspective Bowel Cancer is the third most common cancer in the UK Bowel Cancer is the third most common cancer in the UK Approximately 34,900 new cases p.a Approximately 34,900 new cases p.a It is is the second largest cause of cancer deaths in the UK (Cancer Research UK, Cancerstats). It is is the second largest cause of cancer deaths in the UK (Cancer Research UK, Cancerstats).

In 2004 approximately 16,100 people died from bowel cancer in the UK, 737 deaths within Cheshire & Merseyside In 2004 approximately 16,100 people died from bowel cancer in the UK, 737 deaths within Cheshire & Merseyside Life time risk of developing Bowel Cancer in the UK is about 1:18 for men and 1:20 for women Life time risk of developing Bowel Cancer in the UK is about 1:18 for men and 1:20 for women Public Health Perspective

Who is at risk of developing bowel cancer? Both men and women People who- – – Take little exercise – – Are overweight – – Have a diet high in red meat and low in vegetables, fruits and fibre

Warrington PCT Strategy For Sport, Physical Activity and Health In Warrington Strategy For Sport, Physical Activity and Health In Warrington Chair Based Exercise Chair Based Exercise Reach for Health Scheme Reach for Health Scheme Warrington Partnership for Food and Health Initiatives Warrington Partnership for Food and Health Initiatives Healthy Weight Strategy Healthy Weight Strategy Food and Health Plan Food and Health Plan Food and Health Workers Food and Health Workers

People with a family history (CRC Relatives) People with a family history (CRC Relatives) Inflammatory Bowel Disease Inflammatory Bowel Disease Genetics- Genetics- – Familial Adenomatous Polyposis (FAP)about 1% of cases – Hereditary Non-Polyposis Colorectal Cancer (HNPCC) about 2-5% of cases Who is at risk of developing bowel cancer? (continued)

The risk of developing bowel cancer increases with age. The risk of developing bowel cancer increases with age. About 80% of people who get Bowel cancer are aged 60 and over About 80% of people who get Bowel cancer are aged 60 and over Who is at risk of developing bowel cancer? (continued)

Colorectal Cancer an Important Health Problem 35,579 new cases in 1999

Colorectal Cancer an Important Health Problem 16,152 deaths in 2001

A persistent change in bowel habit, or diarrhoea for several weeks A persistent change in bowel habit, or diarrhoea for several weeks Rectal bleeding without any obvious reason Rectal bleeding without any obvious reason Anaemia Anaemia Bowel Cancer Symptoms

Abdominal pain, especially if it is severe; and a palpable lump in the abdomen. Abdominal pain, especially if it is severe; and a palpable lump in the abdomen. Increased suspicion if symptoms last for four to six weeks. Increased suspicion if symptoms last for four to six weeks. Nausea, anorexia Nausea, anorexia Weight loss Weight loss Bowel Cancer Symptoms

Wilson and Jungner Criteria for Population Screening Is it an important Health problem ? Is it an important Health problem ? Is effective treatment available ? Is effective treatment available ? Does the disease have an early or latent stage ? Does the disease have an early or latent stage ? Is there a suitable screening test ? Is there a suitable screening test ? Are diagnostic and treatment facilities available ? Are diagnostic and treatment facilities available ?

Wilson and Jungner Criteria for Population Screening Is the Natural History of the condition known? Is the Natural History of the condition known? Is there agreed criteria for who should be treated ? Is there agreed criteria for who should be treated ? Is the programme a continuing process ? Is the programme a continuing process ? Is the programme economically viable? Is the programme economically viable?

Why not increase access for Symptomatic patients? 30% of colorectal cancers present as emergencies 30% of colorectal cancers present as emergencies The 2 week rule has had no impact The 2 week rule has had no impact 5% 2 week rule referrals have colorectal cancers 5% 2 week rule referrals have colorectal cancers As yet there has been no shift in Dukes stage As yet there has been no shift in Dukes stage

Natural History Adenoma- Carcinoma Sequence Morson 1960s Normal Mucosa Adenoma High Risk Adenoma Carcinoma Prevalence in 50 yr olds 18%4%0.25%

Diagram of the Bowel

Dukes Staging Diagram 100% 90% 65% 25% 15% 5 yr survival 11% 33% 33% 23% Proportion A=85-95% B=60-80% C=30-60% D=<10% 5 year survival

In 2000 the Bowel Cancer screening Pilot began in Scotland (Dundee) and England (Rugby) In 2000 the Bowel Cancer screening Pilot began in Scotland (Dundee) and England (Rugby) Evidence from pilot studies showed that early detection through regular Bowel Cancer Screening has a significant impact upon overall survival rates Evidence from pilot studies showed that early detection through regular Bowel Cancer Screening has a significant impact upon overall survival rates BCSP can reduce mortality (deaths) by 16% in the population invited for screening BCSP can reduce mortality (deaths) by 16% in the population invited for screening Bowel Cancer Screening Pilot

Nottingham study Stage shift Dukes stage ABCD Screen20%33%24%21% Controls11%32%31%22% Hardcastle, 1996

Health Inequalities of the BCSP Pilot Men were less likely to participate in FOBt Lower uptake in deprived areas. Poor uptake in Black and Ethnic Minority groups particularly Muslims. Ethnic groups more likely to DNA before colonoscopy.

Other groups who may experience inequalities – – Learning disabilities/ difficulties – – Blind and Visual impairment – – Deaf – – People with mobility problems – – Illiterate – – Mental illness – – Travellers – – Homeless – – Prison population Health Inequalities of the BCSP

Responsibility for the BCSP Cheshire & Merseyside NHS North West have the lead responsibility for BCSP initially. Thereafter PCT’s will commission the programme. Cheshire & Merseyside NHS North West have the lead responsibility for BCSP initially. Thereafter PCT’s will commission the programme. Central budget £10 million first wave, second wave also funded approximately £461K per 500,000 head of population Central budget £10 million first wave, second wave also funded approximately £461K per 500,000 head of population

Agreed Model Consortium Approach Consortium Approach Local Implementation Group Local Implementation Group Key stakeholder consensus reached Key stakeholder consensus reached

Operationally driven and managed by 1 host Trust.( Aintree) This is the local BCSP administration centre. Operationally driven and managed by 1 host Trust.( Aintree) This is the local BCSP administration centre. Endoscopy nurse-led screening assessment clinics (community) Endoscopy nurse-led screening assessment clinics (community) Agreed Model

Quality Assurance Standards Global Rating Scores (Patient experience) Global Rating Scores (Patient experience) Satisfactory Joint Advisory Group (JAG) assessment & visitation Satisfactory Joint Advisory Group (JAG) assessment & visitation Accreditation of colonoscopists Accreditation of colonoscopists Health Promotion and Health Inequality considerations( Uptake, awareness) Health Promotion and Health Inequality considerations( Uptake, awareness)

SHA BCSP Statistics Screening population 327,683 Screening population 327,683 Assume 60% uptake based on pilot figures = 196,610 of which, Assume 60% uptake based on pilot figures = 196,610 of which, Approximate 2% will have a positive FOBt = 3,932 of which, Approximate 2% will have a positive FOBt = 3,932 of which, 11% of FOBt positive patients will have cancer = % of FOBt positive patients will have cancer = % will have polyps requiring surveillance = % will have polyps requiring surveillance =1376

Proposed organisation HUB 5 Programme Hubs across England, based on IT Local Service Providers (LSP) undertaking call/recall and lab functions 1 Programme Hub for approx 20 screening centres Overarching Structure:

Role of HUB To Manage call and recall for the screening programme To Manage call and recall for the screening programme To provide a telephone help line for people invited for screening To provide a telephone help line for people invited for screening To dispatch and process test kits To dispatch and process test kits Send results letters to participants and notify GP Send results letters to participants and notify GP Book the first appointment at a nurse led clinic for patients with an abnormal test result Book the first appointment at a nurse led clinic for patients with an abnormal test result Coordinate Quality assurance activities Coordinate Quality assurance activities

BCSP Process FOB testing will be offered to all men & women aged yearly. FOB testing will be offered to all men & women aged yearly.

70+ can request to join the BCSP but have to contact Regional Hub at Rugby. 70+ can request to join the BCSP but have to contact Regional Hub at Rugby. BCSP Process

Faecal Occult Blood Testing (FOBT) - Guaiac Testing The participant is instructed to smear the stool onto the spots from 2 separate parts of the specimen on three separate days

Model in brief Invitation letter is sent to participant from Rugby dispatch centre (HUB). Invitation letter is sent to participant from Rugby dispatch centre (HUB). Participants can opt out of the BCSP by contacting Rugby. Participants can opt out of the BCSP by contacting Rugby.

Rugby

Administrative Offices

Pathology

Laboratory

Envelope Prepared

FOBt Kits

Preparing Kit

Preparation of Kit

Solution Added To Process Kit

Results to be checked

Normal result

Abnormal Result

Data base

National hub despatch kit Participants smear the stool sample onto the 2 Squares in the 1 st flap indicated on the kit. This is repeated on 2 further days until all 6 Squares are completed Model in brief

Screening Journey Completed kit is returned by post to Rugby within 2 weeks of the 1 st sample being smeared on the kit (foil-lined envelope supplied) Completed kit is returned by post to Rugby within 2 weeks of the 1 st sample being smeared on the kit (foil-lined envelope supplied)

Results  Negative result  Unclear Result (1-4 of the squares are positive)  Spoilt Kit  Technical Failure  Positive Result

Screening Centres They will provide nurse led clinics for patients with an abnormal test result They will provide nurse led clinics for patients with an abnormal test result Arrange colonoscopy appointments for patients with an abnormal test result Arrange colonoscopy appointments for patients with an abnormal test result Arrange alternative appointments for patients in whom colonoscopy has failed Arrange alternative appointments for patients in whom colonoscopy has failed Ensure appropriate follow-up or treatment for patients after colonoscopy Ensure appropriate follow-up or treatment for patients after colonoscopy

Screening Centres Provide information about the screening programme for the local health community Provide information about the screening programme for the local health community Promote the screening programme to the Promote the screening programme to the general public in their locality Provide information and support for local people in completing the FOB test(on referral from the programme hub Provide information and support for local people in completing the FOB test(on referral from the programme hub

Appointment arranged at Endoscopy Nurse screening assessment clinic if the FOBt is positive. The participant will receive: Counselling A health questionnaire Information Consent Preparation for the procedure Bowel Cancer Screening-The colonoscopy Investigation (leaflet) Screening Journey

Screening journey (Continued) Referred to screening provider unit for colonoscopy Follow-up dependant on procedure results – – Normal, sent a BCSP kit in 2 years – – Polyps, surveillance by BCSP – – Cancer detected cases referred to local Multi Disciplinary Team (local Cancer Team)

Role of Primary Care Encourage members of the public to participate in the BCSP Encourage members of the public to participate in the BCSP Provide general information on the BCSP to participants Provide general information on the BCSP to participants Direct inquiries to the national freephone help-line telephone service Direct inquiries to the national freephone help-line telephone service

Role of Primary Care Add results to the GP practice IT systems Add results to the GP practice IT systems Encourage patients to complete the whole BCSP process. Encourage patients to complete the whole BCSP process. GP will be notified if patients DNA or opt out of the programme GP will be notified if patients DNA or opt out of the programme

Contact Details Maureen Sayer Maureen Sayer Health Improvement Practitioner